Cardiac masses diagnosis and treatment are a true challenge,although they are infrequently encountered in clinical practice.They encompass a broad set of lesions that include neoplastic(primary and secondary),non-neop...Cardiac masses diagnosis and treatment are a true challenge,although they are infrequently encountered in clinical practice.They encompass a broad set of lesions that include neoplastic(primary and secondary),non-neoplastic masses and pseudomasses.The clinical presentation of cardiac tumors is highly variable and depends on several factors such as size,location,relation with other structures and mobility.The presumptive diagnosis is made based on a preliminary non-invasive diagnostic work-up due to technical difficulties and risks associated with biopsy,which is still the diagnostic gold standard.The findings should always be interpreted in the clinical context to avoid misdiagnosis,particularly in specific conditions(e.g.,infective endocarditis or thrombi).The modern multi-modality imaging techniques has a key role not only for the initial assessment and differential diagnosis but also for management and surveillance of the cardiac masses.Cardiovascular magnetic resonance(CMR)allows an optimal non-invasive localization of the lesion,providing multiplanar information on its relation to surrounding structures.Moreover,with the additional feature of tissue characterization,CMR can be highly effective to distinguish pseudomasses from masses,as well as benign from malignant lesions,with further differential diagnosis of the latter.Although histopathological assessment is important to make a definitive diagnosis,CMR plays a key role in the diagnosis of suspected cardiac masses with a great impact on patient management.This literature review aims to provide a comprehensive overview of cardiac masses,from clinical and imaging protocol to pathological findings.展开更多
INTRODUCTION The incidence of fetal cardiac tumor was about 0.14% as determined by fetal echocardiography. It was extremely difficult to deal with the fetus when the severe circulatory instability was induced by a car...INTRODUCTION The incidence of fetal cardiac tumor was about 0.14% as determined by fetal echocardiography. It was extremely difficult to deal with the fetus when the severe circulatory instability was induced by a cardiac tumor in the womb. It was reported that ex utero intrapartum treatment （EXIT） procedure solved the problems of fetal airway or pulmonary lesion during delivery to avoid hypoxia after birth. The goal of EXIT is to maintain placental circulation while steps are taken to optimize the transition of the baby from fetal to neonatal life. This study introduced the experience of EXIT procedure to solve the problems of fetal circulation induced by a fetal cardiac tumor.展开更多
The incidence of primary cardiac tumors is extremely low, ranging from 0.0017% to 0.019%.^1 Primarytumors can be categorized into benign or malignant tumors, in which 75% of primary tumors are benign with myxomas comp...The incidence of primary cardiac tumors is extremely low, ranging from 0.0017% to 0.019%.^1 Primarytumors can be categorized into benign or malignant tumors, in which 75% of primary tumors are benign with myxomas comprising 50% of the cases. On the other hand, malignant tumors constitute less than 25% of primary cardiac neoplasms and are manifested predominantly as sarcoma in various forms.展开更多
Primary cardiac lymphoma （PCL） is an extremely rare entity that accounts for only 0.5% of extranodal lymphomas and 1.0% of cardiac tumors.[1] Because the tumor is clinically aggressive and fatal,it is of great signi...Primary cardiac lymphoma （PCL） is an extremely rare entity that accounts for only 0.5% of extranodal lymphomas and 1.0% of cardiac tumors.[1] Because the tumor is clinically aggressive and fatal,it is of great significant to diagnose this disease and treat it promptly.Nevertheless,The diagnosis of PCL is very difficult due to its nonspecific clinical manifestations.[1] Herein,we report the imaging findings in two cases of PCL.展开更多
文摘Cardiac masses diagnosis and treatment are a true challenge,although they are infrequently encountered in clinical practice.They encompass a broad set of lesions that include neoplastic(primary and secondary),non-neoplastic masses and pseudomasses.The clinical presentation of cardiac tumors is highly variable and depends on several factors such as size,location,relation with other structures and mobility.The presumptive diagnosis is made based on a preliminary non-invasive diagnostic work-up due to technical difficulties and risks associated with biopsy,which is still the diagnostic gold standard.The findings should always be interpreted in the clinical context to avoid misdiagnosis,particularly in specific conditions(e.g.,infective endocarditis or thrombi).The modern multi-modality imaging techniques has a key role not only for the initial assessment and differential diagnosis but also for management and surveillance of the cardiac masses.Cardiovascular magnetic resonance(CMR)allows an optimal non-invasive localization of the lesion,providing multiplanar information on its relation to surrounding structures.Moreover,with the additional feature of tissue characterization,CMR can be highly effective to distinguish pseudomasses from masses,as well as benign from malignant lesions,with further differential diagnosis of the latter.Although histopathological assessment is important to make a definitive diagnosis,CMR plays a key role in the diagnosis of suspected cardiac masses with a great impact on patient management.This literature review aims to provide a comprehensive overview of cardiac masses,from clinical and imaging protocol to pathological findings.
文摘INTRODUCTION The incidence of fetal cardiac tumor was about 0.14% as determined by fetal echocardiography. It was extremely difficult to deal with the fetus when the severe circulatory instability was induced by a cardiac tumor in the womb. It was reported that ex utero intrapartum treatment （EXIT） procedure solved the problems of fetal airway or pulmonary lesion during delivery to avoid hypoxia after birth. The goal of EXIT is to maintain placental circulation while steps are taken to optimize the transition of the baby from fetal to neonatal life. This study introduced the experience of EXIT procedure to solve the problems of fetal circulation induced by a fetal cardiac tumor.
文摘The incidence of primary cardiac tumors is extremely low, ranging from 0.0017% to 0.019%.^1 Primarytumors can be categorized into benign or malignant tumors, in which 75% of primary tumors are benign with myxomas comprising 50% of the cases. On the other hand, malignant tumors constitute less than 25% of primary cardiac neoplasms and are manifested predominantly as sarcoma in various forms.
文摘Primary cardiac lymphoma （PCL） is an extremely rare entity that accounts for only 0.5% of extranodal lymphomas and 1.0% of cardiac tumors.[1] Because the tumor is clinically aggressive and fatal,it is of great significant to diagnose this disease and treat it promptly.Nevertheless,The diagnosis of PCL is very difficult due to its nonspecific clinical manifestations.[1] Herein,we report the imaging findings in two cases of PCL.
